Ming De Xia
Amministratore Delegato presso Innolake Pharmaceuticals (Hangzhou) Co., Ltd.
Profilo
Ming De Xia has founded Innolake Pharmaceuticals (Hangzhou) Co., Ltd.
in 2020 and currently holds the position of Chairman & Chief Executive Officer.
Posizioni attive di Ming De Xia
| Società | Posizione | Inizio |
|---|---|---|
Innolake Pharmaceuticals (Hangzhou) Co., Ltd.
 Innolake Pharmaceuticals (Hangzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Innolake Pharmaceuticals (Hangzhou) Co., Ltd. is a company based in Hangzhou, China that engages in the development and commercialization of therapeutic drugs for tumors and immune system diseases. The Chinese company was founded in 2020 by Ru Lei Chen and Ming De Xia, with Ming De Xia serving as the CEO since 2020. | Amministratore Delegato | 01/12/2020 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Innolake Pharmaceuticals (Hangzhou) Co., Ltd.
Innolake Pharmaceuticals (Hangzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Innolake Pharmaceuticals (Hangzhou) Co., Ltd. is a company based in Hangzhou, China that engages in the development and commercialization of therapeutic drugs for tumors and immune system diseases. The Chinese company was founded in 2020 by Ru Lei Chen and Ming De Xia, with Ming De Xia serving as the CEO since 2020. | Health Technology |
- Borsa valori
- Insiders
- Ming De Xia
